Angélica M Amanso1, Bernard Lassègue1, Giji Joseph1, Natalia Landázuri1, James S Long1, Daiana Weiss1, W Robert Taylor1, Kathy K Griendling2. 1. From the Department of Medicine, Division of Cardiology (A.M.A., B.L., G.J., J.S.L., D.W., W.R.T., K.K.G.) and The Wallace H. Coulter Department of Biomedical Engineering (W.R.T.), Emory University, Atlanta, GA; and Department of Medicine, Division of Cardiology, Atlanta VA Medical Center, GA (W.R.T.). 2. From the Department of Medicine, Division of Cardiology (A.M.A., B.L., G.J., J.S.L., D.W., W.R.T., K.K.G.) and The Wallace H. Coulter Department of Biomedical Engineering (W.R.T.), Emory University, Atlanta, GA; and Department of Medicine, Division of Cardiology, Atlanta VA Medical Center, GA (W.R.T.). kgriend@emory.edu.
Abstract
OBJECTIVE: Collateral vessel formation can functionally compensate for obstructive vascular lesions in patients with atherosclerosis. Neovascularization processes are triggered by fluid shear stress, hypoxia, growth factors, chemokines, proteases, and inflammation, as well as reactive oxygen species, in response to ischemia. Polymerase δ-interacting protein 2 (Poldip2) is a multifunctional protein that regulates focal adhesion turnover and vascular smooth muscle cell migration and modifies extracellular matrix composition. We, therefore, tested the hypothesis that loss of Poldip2 impairs collateral formation. APPROACH AND RESULTS: The mouse hindlimb ischemia model has been used to understand mechanisms involved in postnatal blood vessel formation. Poldip2(+/-) mice were subjected to femoral artery excision, and functional and morphological analysis of blood vessel formation was performed after injury. Heterozygous deletion of Poldip2 decreased the blood flow recovery and spontaneous running activity at 21 days after injury. H2O2 production, as well as the activity of matrix metalloproteinases-2 and -9, was reduced in these animals compared with Poldip2(+/+) mice. Infiltration of macrophages in the peri-injury muscle was also decreased; however, macrophage phenotype was similar between genotypes. In addition, the formation of capillaries and arterioles was impaired, as was angiogenesis, in agreement with a decrease in proliferation observed in endothelial cells treated with small interfering RNA against Poldip2. Finally, regression of newly formed vessels and apoptosis was more pronounced in Poldip2(+/-) mice. CONCLUSIONS: Together, these results suggest that Poldip2 promotes ischemia-induced collateral vessel formation via multiple mechanisms that likely involve reactive oxygen species-dependent activation of matrix metalloproteinase activity, as well as enhanced vascular cell growth and survival.
OBJECTIVE: Collateral vessel formation can functionally compensate for obstructive vascular lesions in patients with atherosclerosis. Neovascularization processes are triggered by fluid shear stress, hypoxia, growth factors, chemokines, proteases, and inflammation, as well as reactive oxygen species, in response to ischemia. Polymerase δ-interacting protein 2 (Poldip2) is a multifunctional protein that regulates focal adhesion turnover and vascular smooth muscle cell migration and modifies extracellular matrix composition. We, therefore, tested the hypothesis that loss of Poldip2 impairs collateral formation. APPROACH AND RESULTS: The mouse hindlimb ischemia model has been used to understand mechanisms involved in postnatal blood vessel formation. Poldip2(+/-) mice were subjected to femoral artery excision, and functional and morphological analysis of blood vessel formation was performed after injury. Heterozygous deletion of Poldip2 decreased the blood flow recovery and spontaneous running activity at 21 days after injury. H2O2 production, as well as the activity of matrix metalloproteinases-2 and -9, was reduced in these animals compared with Poldip2(+/+) mice. Infiltration of macrophages in the peri-injury muscle was also decreased; however, macrophage phenotype was similar between genotypes. In addition, the formation of capillaries and arterioles was impaired, as was angiogenesis, in agreement with a decrease in proliferation observed in endothelial cells treated with small interfering RNA against Poldip2. Finally, regression of newly formed vessels and apoptosis was more pronounced in Poldip2(+/-) mice. CONCLUSIONS: Together, these results suggest that Poldip2 promotes ischemia-induced collateral vessel formation via multiple mechanisms that likely involve reactive oxygen species-dependent activation of matrix metalloproteinase activity, as well as enhanced vascular cell growth and survival.
Authors: Craig L Duvall; W Robert Taylor; Daiana Weiss; Robert E Guldberg Journal: Am J Physiol Heart Circ Physiol Date: 2004-03-11 Impact factor: 4.733
Authors: Zorina S Galis; Chad Johnson; Denis Godin; Richard Magid; J Michael Shipley; Robert M Senior; Eugen Ivan Journal: Circ Res Date: 2002-11-01 Impact factor: 17.367
Authors: Bart E Muhs; George Plitas; Yara Delgado; Ioana Ianus; Jason P Shaw; Mark A Adelman; Patrick Lamparello; Peter Shamamian; Paul Gagne Journal: J Surg Res Date: 2003-05-01 Impact factor: 2.192
Authors: Lauren Parker Huff; Daniel Seicho Kikuchi; Elizabeth Faidley; Steven J Forrester; Michelle Z Tsai; Bernard Lassègue; Kathy K Griendling Journal: Am J Physiol Cell Physiol Date: 2019-02-06 Impact factor: 4.249
Authors: Sasa Vukelic; Qian Xu; Bonnie Seidel-Rogol; Elizabeth A Faidley; Anna E Dikalova; Lula L Hilenski; Ulrich Jorde; Leslie B Poole; Bernard Lassègue; Guogang Zhang; Kathy K Griendling Journal: Arterioscler Thromb Vasc Biol Date: 2018-10 Impact factor: 8.311
Authors: Felipe Paredes; Kely Sheldon; Bernard Lassègue; Holly C Williams; Elizabeth A Faidley; Gloria A Benavides; Gloria Torres; Fernanda Sanhueza-Olivares; Samantha M Yeligar; Kathy K Griendling; Victor Darley-Usmar; Alejandra San Martin Journal: Proc Natl Acad Sci U S A Date: 2018-02-06 Impact factor: 11.205
Authors: Srinivasa Raju Datla; Lula L Hilenski; Bonnie Seidel-Rogol; Anna E Dikalova; Mark Harousseau; Lili Punkova; Giji Joseph; W Robert Taylor; Bernard Lassègue; Kathy K Griendling Journal: Lab Invest Date: 2018-09-20 Impact factor: 5.662
Authors: Marina S Hernandes; Bernard Lassègue; Lula L Hilenski; Jonathan Adams; Ning Gao; Chia-Yi Kuan; Yu-Yo Sun; Lihong Cheng; Daniel S Kikuchi; Manuel Yepes; Kathy K Griendling Journal: J Neuroinflammation Date: 2018-02-17 Impact factor: 8.322